These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8468528

  • 21. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
    Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rall SC.
    J Biol Chem; 1992 Jan 25; 267(3):1962-8. PubMed ID: 1730728
    [Abstract] [Full Text] [Related]

  • 22. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    Schmitz G, Assmann G, Augustin J, Dirkes-Kersting A, Brennhaüsen B, Karoff C.
    J Lipid Res; 1985 Mar 25; 26(3):316-26. PubMed ID: 3989390
    [Abstract] [Full Text] [Related]

  • 23. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
    Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB.
    J Clin Invest; 1986 Sep 25; 78(3):815-21. PubMed ID: 3745440
    [Abstract] [Full Text] [Related]

  • 24. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P, van den Maagdenberg AM, Boomsma DI, Stalenhoef AF, Smelt AH, Kastelein JJ, Marais AD, Frants RR, Havekes LM.
    J Clin Invest; 1994 Sep 25; 94(3):1252-62. PubMed ID: 8083367
    [Abstract] [Full Text] [Related]

  • 25. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
    Mulder M, van der Boom H, de Knijff P, Braam C, van den Maagdenberg A, Leuven JA, Havekes LM.
    Atherosclerosis; 1994 Aug 25; 108(2):183-92. PubMed ID: 7980718
    [Abstract] [Full Text] [Related]

  • 26. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.
    Weisgraber KH.
    J Lipid Res; 1990 Aug 25; 31(8):1503-11. PubMed ID: 2280190
    [Abstract] [Full Text] [Related]

  • 27. The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly.
    Fazio S, Yao Z.
    Arterioscler Thromb Vasc Biol; 1995 May 25; 15(5):593-600. PubMed ID: 7749873
    [Abstract] [Full Text] [Related]

  • 28. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 29. Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
    Minnich A, Weisgraber KH, Newhouse Y, Dong LM, Fortin LJ, Tremblay M, Davignon J.
    J Lipid Res; 1995 Jan 01; 36(1):57-66. PubMed ID: 7706948
    [Abstract] [Full Text] [Related]

  • 30. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ, Beer FD, Vark LC, Havekes LM, Hofker MH, Willems Van Dijk K.
    Biochem J; 2000 Apr 15; 347(Pt 2):357-61. PubMed ID: 10749663
    [Abstract] [Full Text] [Related]

  • 31. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture.
    Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13429-36. PubMed ID: 8175774
    [Abstract] [Full Text] [Related]

  • 32. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley RW.
    Arterioscler Thromb Vasc Biol; 1999 Dec 06; 19(12):2952-9. PubMed ID: 10591675
    [Abstract] [Full Text] [Related]

  • 33. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR, Jong MC, van Goor H, van Luyn MJ, Bloks V, Havinga R, Voshol PJ, Hofker MH, van Dijk KW, Havekes LM, Kuipers F.
    J Biol Chem; 1999 Dec 10; 274(50):35711-8. PubMed ID: 10585451
    [Abstract] [Full Text] [Related]

  • 34. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW.
    J Biol Chem; 1993 May 15; 268(14):10160-7. PubMed ID: 7683668
    [Abstract] [Full Text] [Related]

  • 35. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
    Croyal M, Blanchard V, Ouguerram K, Chétiveaux M, Cabioch L, Moyon T, Billon-Crossouard S, Aguesse A, Bernardeau K, Le May C, Flet L, Lambert G, Hadjadj S, Cariou B, Krempf M, Nobécourt-Dupuy E.
    Arterioscler Thromb Vasc Biol; 2020 Mar 15; 40(3):819-829. PubMed ID: 32078365
    [Abstract] [Full Text] [Related]

  • 36. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
    Tsukamoto K, Maugeais C, Glick JM, Rader DJ.
    J Lipid Res; 2000 Feb 15; 41(2):253-9. PubMed ID: 10681409
    [Abstract] [Full Text] [Related]

  • 37. Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.
    Wardell MR, Weisgraber KH, Havekes LM, Rall SC.
    J Biol Chem; 1989 Dec 15; 264(35):21205-10. PubMed ID: 2556398
    [Abstract] [Full Text] [Related]

  • 38. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA, Gregg RE, Sprecher DL, Brewer HB.
    Biochim Biophys Acta; 1989 Oct 17; 1005(3):239-44. PubMed ID: 2804053
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels.
    Li H, Dhanasekaran P, Alexander ET, Rader DJ, Phillips MC, Lund-Katz S.
    Arterioscler Thromb Vasc Biol; 2013 Apr 17; 33(4):687-93. PubMed ID: 23413428
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.